Dianne Whitfield Net Worth & Insider Trades
Dianne Whitfield - Chief Human Resources Officer, Tarsus Pharmaceuticals, Inc
What is Dianne Whitfield's Net Worth?
The current estimated net worth of Tarsus Pharmaceuticals, Inc's Chief Human Resources Officer, Dianne Whitfield, is estimated to be about $225.06K . Dianne Whitfield owns about 11,219 units of Tarsus Pharmaceuticals, Inc common stock. In the last 2 years at Tarsus Pharmaceuticals, Inc, Dianne Whitfield has sold an estimated value of $83.72K worth.
What is Dianne Whitfield's Past Insider Trading?
Dianne Whitfield's largest sale order was 2,347 units , worth over $39.02K on December 1, 2022. In total, Dianne Whitfield has made about 8 transactions over 2 years of their time at Tarsus Pharmaceuticals, Inc. Dianne Whitfield usually trades in March, with the busiest year in 2023. The most recent transaction was a sale order of 1,004 units , worth over $12.6K on March 23, 2023.
Dianne Whitfield
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Dianne Whitfield's' Mailing Address?
- Mailing address is 15440 Laguna Canyon Road, Suite 160 Irvine CA 92618 CA
Tarsus Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Bobak Azamian, M.D. Ph.D. | 2020 | $437,000 | $211,484 | $1,847,092 | $14,820 | $2,510,396 |
| Bobak Azamian, M.D. Ph.D. | 2019 | $300,000 | $116,137 | - | - | $416,137 |
| Leo Greenstein | 2020 | $256,023 | $147,437 | $418,703 | $13,280 | $835,443 |
| Seshadri Neervannan, Ph.D.. | 2020 | $199,621 | $85,248 | $1,926,633 | $2,175 | $2,213,677 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1819790/000119312521144962/d150509ddef14a.htm
What are Tarsus Pharmaceuticals, Inc's Past Insider Trades?
Tarsus Pharmaceuticals, Inc's most recent insider trade came on May 19, 2023 by Bobak Azamian who sold 8,000 units worth $127.2K . In the last 3 years, insiders at Tarsus Pharmaceuticals, Inc have sold an estimated value of $33.4M and bought an estimated value of $16.44M worth of shares. Insider trading is most common in March, with the busiest year in 2023. The most active traders at the company are Bobak Azamian, President/CEO and Board Chair, Leonard M Greenstein, Chief Financial Officer, and Michael Ackermann, Director .
Tarsus Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||